Article PDF
Avoid common mistakes on your manuscript.
Abbreviations
- IDDM:
-
Insulin-dependent diabetes mellitus
- NIDDM:
-
non-insulin-dependent diabetes mellitus
- IRS:
-
insulin resistance syndrome
- PAI-1:
-
plasminogen activator-inhibitor-1
References
Jarrett RJ (1994) Why is insulin not a risk factor for coronary heart disease? Diabetologia 37: 945–947
Reaven GM, Laws A (1994) Insulin resistance, compensatory hyperinsulinaemia, and coronary heart disease. Diabetologia 37: 948–952
Fontbonne A (1994) Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia 37: 953–955
Stern MP (1994) The insulin resistance syndrome. In: KGMM Alberti, RA DeFronzo, P. Zimmet (eds) International textbook of diabetes mellitus. John Wiley and Sons, Ltd. Chichester
Stern MP, Morales PA, Valdez RA, Monterrosa A, Haffner SM, Mitchell BD, Hazuda HP (1993) Predicting diabetes: moving beyond impaired glucose tolerance. Diabetes 42: 706–714
Haffner S, Mykkänen L, Bowsher R (1994) Proinsulin, insulin and proinsulin/insulin ratio in non-diabetic Mexican Americans and non-Hispanic whites. Diabetes 43 [Suppl 1]: 151 A (Abstract)
Temple RC, Clark P, Schneider A, Nagi DK, Yudkin JS, Hales CN (1990) Radioimmunoassay may overestimate insulin in non-insulin dependent diabetics. Clin Endocrinol 32: 689–693
Ward WK, La Cova EC, Paquette TL, Beard JC, Wallum BJ, Porte D (1987) Disproportionate elevation of immunoreactive proinsulin in type II (non-insulin-dependent) diabetes mellitus and in experimental insulin resistance. Diabetologia 30: 698–702
Davies M, Rayman G, Gray IP, Day JL, Hales CN (1993) Insulin deficiency and increased plasma concentrations of intact and 32/33 split proinsulin in subjects with impaired glucose tolerance. Diabet Med 10: 313–320
Saad MF, Kahn SE, Nelson RG et al. (1990) Disproportionately elevated proinsulin in Pima Indians with non-insulin dependent diabetes mellitus. J Clin Endocrinol Metab 70: 1247–1253
Nagi DK, Hendra TJ, Ryle AJ et al. (1990) The relationship of concentrations of insulin, intact proinsulin and 32–33 split proinsulin with cardiovascular risk factors in type 2 (noninsulin-dependent) diabetic subjects. Diabetologia 33: 532–537
Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR (1993) Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes 42: 1297–1302
Haffner SM, Stern MP, Hazuda HP, Mitchell BD, Patterson JK (1990) Cardiovascular risk factors in confirmed prediabetics: does the clock for coronary heart disease start ticking before the onset of clinical diabetes? JAMA 263: 2893–2898
The Diabetes Control and Complications Trial Research Group (1993) The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New Eng J Med 329: 977–986
American Diabetes Association (1993) Implications of the Diabetes Control and Complications Trial. Diabetes Care 16: 1517–1520
Stern MP, Haffner SM (1991) Dyslipidemia in type II diabetes. Implications for therapeutic intervention. Diabetes Care 14: 1144–1159
Abraira C, Johnson N, Colwell J, and the VA CSDM Group (1994) VA Cooperative Study on Glycemic Control and Complications in Type II Diabetes (VA CSDM): results of the completed feasibility trial. Diabetes 43 [Suppl 1]: 59 A (Abstract)
University Group Diabetes Program (1970) A study of the effect of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. mortality results. Diabetes 19 [Suppl 2]: 785–830
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stern, M.P. The insulin resistance syndrome: the controversy is dead, long live the controversy!. Diabetologia 37, 956–958 (1994). https://doi.org/10.1007/BF00400955
Issue Date:
DOI: https://doi.org/10.1007/BF00400955